Ranolazine reduces repolarization heterogeneity in  symptomatic patients with diabetes and non–flow‐limiting coronary artery stenosis

ConclusionsIn symptomatic diabetic patients with non‐flow‐limiting coronary artery stenosis with diffuse atherosclerosis and/or microvascular dysfunction, ranolazine reduced TWH at rest but not during exercise. Reduction in repolarization abnormalities appears to be independent of alterations in MBF.

Source: Annals of Noninvasive Electrocardiology - May 1, 2017 Category: Cardiology Authors: Ederson Evaristo, Fernando G. Stocco, Nishant R. Shah, Michael K. Cheezum, Jon Hainer, Courtney Foster, Bruce D. Nearing, Marcelo Di Carli, Richard L. Verrier Tags: ORIGINAL ARTICLE Source Type: research